Dianthus Therapeutics (DNTH) EBIT Growth (5y) (2022 - 2025)

Dianthus Therapeutics (DNTH) EBIT Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Dianthus Therapeutics 3.92 Bn 3.51 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -16.99%
Jun 30, 2025 -11.78%
Mar 31, 2025 -9.33%
Dec 31, 2024 -5.31%
Sep 30, 2024 -5.72%
Jun 30, 2024 -2.80%
Mar 31, 2024 -1.76%
Dec 31, 2023 6.29%
Sep 30, 2023 1.16%
Jun 30, 2023 3.44%
Mar 31, 2023 7.44%
Dec 31, 2022 -5.53%
Sep 30, 2022 -3.31%
Jun 30, 2022 -2.83%